Cargando…

Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement

PURPOSE: The unified multiple system atrophy (MSA) rating scale (UMSARS) was developed almost 20 years ago as a clinical rating scale to capture multiple aspects of the disease. With its widespread use, the shortcomings of the UMSARS as a clinical outcome assessment (COA) have become increasingly ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palma, Jose-Alberto, Vernetti, Patricio Millar, Perez, Miguel A., Krismer, Florian, Seppi, Klaus, Fanciulli, Alessandra, Singer, Wolfgang, Low, Phillip, Biaggioni, Italo, Norcliffe-Kaufmann, Lucy, Pellecchia, Maria Teresa, Martí, Maria José, Kim, Han-Joon, Merello, Marcelo, Stankovic, Iva, Poewe, Werner, Betensky, Rebecca, Wenning, Gregor, Kaufmann, Horacio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868077/ https://www.ncbi.nlm.nih.gov/pubmed/33554315 http://dx.doi.org/10.1007/s10286-021-00782-w

Ejemplares similares

Long-Term Outcomes of Hyperadrenergic Orthostatic Hypotension
por: Castro, Robert Alexander, et al.
Publicado: (2023)

Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis
por: Bajaj, Sweta, et al.
Publicado: (2017)

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022)

Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial
por: Kaufmann, Horacio, et al.
Publicado: (2021)

The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations
por: Krismer, Florian, et al.
Publicado: (2022)

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
por: Wenning, Gregor K., et al.
Publicado: (2022)

Sensitivity to Change and Patient‐Centricity of the Unified Multiple System Atrophy Rating Scale Items: A Data‐Driven Analysis
por: Krismer, Florian, et al.
Publicado: (2022)

Parkin Pleiotropy: Extremely Atypical Phenotypes in Patients With Compound Heterozygous Mutations
por: Millar Vernetti, Patricio, et al.
Publicado: (2020)

Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension
por: Biaggioni, Italo, et al.
Publicado: (2017)

Genetic Diagnosis in Movement Disorders. Use of Whole-Exome Sequencing in Clinical Practice
por: Millar Vernetti, Patricio, et al.
Publicado: (2022)

Developmental Abnormalities, Blood Pressure Variability and Renal Disease In Riley Day Syndrome
por: Norcliffe-Kaufmann, Lucy, et al.
Publicado: (2011)

Height, weight, and body mass index in patients with familial dysautonomia
por: Cotrina, Maria L., et al.
Publicado: (2023)

The Retina in Multiple System Atrophy: Systematic Review and Meta-Analysis
por: Mendoza-Santiesteban, Carlos E., et al.
Publicado: (2017)

Expanding the Genotypic Spectrum of Congenital Sensory and Autonomic Neuropathies Using Whole-Exome Sequencing
por: Palma, Jose-Alberto, et al.
Publicado: (2021)

Randomized Withdrawal Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension Responsive to Droxidopa
por: Biaggioni, Italo, et al.
Publicado: (2015)

Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH)
por: Fanciulli, Alessandra, et al.
Publicado: (2018)

A Review on the Clinical Diagnosis of Multiple System Atrophy
por: Stankovic, Iva, et al.
Publicado: (2022)

Disturbances in affective touch in hereditary sensory & autonomic neuropathy type III
por: Macefield, Vaughan G., et al.
Publicado: (2014)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease
por: Krismer, Florian, et al.
Publicado: (2020)

Cognition in multiple system atrophy: a single‐center cohort study
por: Eschlböck, Sabine, et al.
Publicado: (2020)

Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis
por: Krismer, Florian, et al.
Publicado: (2019)

Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors
por: Kühnel, Line, et al.
Publicado: (2022)

Urodynamic Evaluation in Multiple System Atrophy: A Retrospective Cohort Study
por: Eschlböck, Sabine, et al.
Publicado: (2021)

Sensor‐based gait analysis in atypical parkinsonian disorders
por: Raccagni, Cecilia, et al.
Publicado: (2018)

Droxidopa for neurogenic orthostatic hypotension: A randomized, placebo-controlled, phase 3 trial
por: Kaufmann, Horacio, et al.
Publicado: (2014)

Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
por: Eckhardt, Christine, et al.
Publicado: (2022)

Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2012)

Intact Olfaction in a Mouse Model of Multiple System Atrophy
por: Krismer, Florian, et al.
Publicado: (2013)

A Comprehensive NMR Analysis of Serum and Fecal Metabolites in Familial Dysautonomia Patients Reveals Significant Metabolic Perturbations
por: Costello, Stephanann M., et al.
Publicado: (2023)

Is 'happy hypoxia' in COVID-19 a disorder of autonomic interoception? A hypothesis
por: González-Duarte, Alejandra, et al.
Publicado: (2020)

Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
por: Grossauer, Anna, et al.
Publicado: (2023)

Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy
por: Sturm, Edith, et al.
Publicado: (2016)

Different assessment tools to detect sarcopenia in patients with Parkinson's disease
por: Valent, Dora, et al.
Publicado: (2022)

α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
por: Grossauer, Anna, et al.
Publicado: (2023)

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson’s disease
por: Hametner, Eva-Maria, et al.
Publicado: (2012)

A multifactorial study on nutritional status, binge eating and physical activity as main factors directly influencing body weight in Parkinson’s disease
por: Bril, Andrea, et al.
Publicado: (2017)

Orthostatic Hypotension in Parkinson's Disease: Do Height and Weight Matter?
por: Campese, Nicole, et al.
Publicado: (2021)

Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?
por: Leys, Fabian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b8q53ufje9rejntavljt6anfl5